erythromycin ethylsuccinate

Term ID

CHEBI:31555

Synonyms

• (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradecan-6-yl]oxy}-6-methyl
• E-Mycin
• E-Mycin E
• E.E.S
• E.E.S 200
• E.E.S 400
• EES
• EryPed
• erythrocin ethyl succinate
• erythromycin 2'-(ethyl butanedioate)
• erythromycin 2'-(ethyl succinate)
• erythromycin ethyl succinate
• erythromycin ethylsuccinate
• erythromycin mono(ethyl succinate)
• erythromycin, mono(ethyl succinate) (ester)
• Erythroped
• Pediamycin
• succinic acid, ethyl ester, monoester with erythromycin
• Wyamycin E

Definition

A erythromycin derivative that is erythromycin A in which the hydroxy group at position 3R is substituted by a (4-ethoxy-4-oxobutanoyl)oxy group. It is used for the treatment of a wide variety of bacterial infections.

References

• CAS:1264-62-6
• CBA:591223
• Drug_Central:1051
• KEGG:C12796
• KEGG:D01361
• LINCS:LSM-3144
• LIPID_MAPS_instance:LMPK05000001
• PMID:10613930
• PMID:1400845
• PMID:14718172
• PMID:15014787
• PMID:15338913
• PMID:1565532
• PMID:16376051
• PMID:16406447
• PMID:17449230
• PMID:1768482
• PMID:19750750
• PMID:20209795
• PMID:20235137
• PMID:2258252
• PMID:23649599
• PMID:2548964
• PMID:6333077
• PMID:6603894
• PMID:6969579
• PMID:6979924
• PMID:7829900
• PMID:8419773
• PMID:8843283
• PMID:9646062
• Patent:CN1602887
• Reaxys:77638

Ontology

ChEBI  ( EBI )

Resources

CTD